<DOC>
	<DOCNO>NCT01629589</DOCNO>
	<brief_summary>The aim study describe immunogenicity single booster dose Adacel vaccine versus Boostrix vaccine among approximately 420 adolescent 11 &lt; 13 year age . Primary objective : - To describe seroprotection rate tetanus diphtheria subject randomize receive either Adacel Boostrix vaccine . Observational objective : - To describe pre- post-vaccination tetanus , diphtheria , pertussis geometric mean antibody concentration ( GMCs ) subject randomize receive either Adacel Boostrix vaccine . - To describe booster response rate tetanus , diphtheria , pertussis subject randomize receive either Adacel Boostrix vaccine . - To describe rate adverse event ( AEs ) immediately post-vaccination , rate unsolicited AEs serious adverse event ( SAEs ) follow vaccination Adacel Boostrix vaccine Visit 1 Visit 2 .</brief_summary>
	<brief_title>Immunogenicity Adacel® BOOSTRIX® Vaccines Adolescents</brief_title>
	<detailed_description>Participants randomize 1:1 ratio receive either Adacel Boostrix vaccine . Subjects monitor immediate reaction 15 minute post-vaccination . Unsolicited adverse event serious adverse event collect Visit 1 Visit 2 .</detailed_description>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subject 11 &lt; 13 year age time vaccination Received exactly 5 dos pertussis vaccine &lt; 7 year age Informed consent assent form sign dated Subject able attend schedule visit comply trial procedure . Subject pregnant , lactating , child bear potential without use effective method contraception practice abstinence least 4 week prior vaccination least 4 week vaccination Any condition , opinion Investigator , would pose health risk participant interfere evaluation vaccine Chronic illness , opinion Investigator , stage might interfere trial conduct completion Known suspect congenital acquired immunodeficiency ; receipt immunosuppressive therapy anticancer chemotherapy radiation therapy within precede 6 month ; longterm systemic corticosteroid therapy ( prednisone equivalent 2 consecutive week ) within past 3 month ) Known suspect receipt wholecell pertussiscontaining vaccine A personal history physiciandiagnosed laboratoryconfirmed pertussis disease within last 2 year A previous severe reaction pertussis , diphtheria tetanus vaccine include immediate anaphylaxis , encephalopathy within 7 day , seizure within 3 day receive vaccine Receipt immune globulin , blood bloodderived product past 3 month Suspected known hypersensitivity vaccine component , history lifethreatening reaction vaccine use trial vaccine contain substance Receipt vaccine within 30 day receive study vaccine , plan receive another vaccine 2nd visit ; except influenza vaccine may receive 30 15 day ( less 15 day ) receive study vaccine Participation another interventional clinical trial investigate vaccine , drug , medical device , medical procedure 30 day precede first study vaccination course study , discretion Sponsor Seropositivity Human Immunodeficiency Virus ( HIV ) , Hepatitis B , Hepatitis C , report subject 's parent/guardian Laboratoryconfirmed thrombocytopenia , may contraindication intramuscular ( IM ) vaccination , discretion Investigator Bleeding disorder receipt anticoagulants 3 week precede inclusion , may contraindication IM vaccination , discretion Investigator Personal history GuillainBarré syndrome Moderate severe acute illness/infection ( accord Investigator judgment ) febrile illness ( temperature ≥ 38.0°C [ ≥ 100.4°F ] ) day vaccination . ( A prospective subject enrol study condition resolve febrile event subside . ) Identified Investigator employee Investigator study center direct involvement propose study , identify immediate family member ( i.e. , parent , spouse , natural adopt child ) Investigator employee direct involvement propose study Deprived freedom administrative court order , emergency setting , hospitalize involuntarily Current alcohol drug use , opinion Investigator , might interfere ability comply trial procedure .</criteria>
	<gender>All</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Adacel® vaccine</keyword>
	<keyword>Tetanus</keyword>
	<keyword>Diphtheria</keyword>
	<keyword>whooping cough</keyword>
	<keyword>Pertussis</keyword>
	<keyword>BOOSTRIX® vaccine</keyword>
</DOC>